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PEOPLE WITH TYPE 2 DIABETES have lower skeletal muscle oxidative capacity (13) due, in part, to reduced mitochondrial biogenesis and volume (4) . Understanding of the signaling pathways and molecular events necessary for mitochondrial biogenesis has increased markedly in the past few years. The transcription factors, nuclear respiratory factor-1 (NRF-1) and NRF-2, activate genes that encode some mitochondrial oxidative enzyme proteins, as well as mitochondrial transcription factor A, which activates mitochondrial DNA transcription and replication (26) . Peroxisome proliferator-activated receptor (PPAR)-␥ coactivator-1␣ (PGC-1␣), in addition to coactivating PPAR-␥, also coactivates PPAR-␣ and NRF-1, as well as induces increased expression of NRF-1 and NRF-2 (26) . Overexpression of PGC-1␣ in mouse muscle increases mitochondrial biogenesis, suggesting that PGC-1␣ is a master regulator of mitochondrial biogenesis in cardiac and skeletal muscle (15) .
Exercise stimulates increases in mitochondrial volume, thereby increasing muscle oxidative capacity (9) . An acute exercise bout has been shown to increase PGC-1␣ mRNA and protein, as well as NRF-1 and NRF-2 mRNA expression in rats (1, 17) . In addition, PGC-1␣ mRNA increases after an acute exercise bout in humans (21, 25) . These data suggest that PGC-1␣, NRF-1, and NRF-2 are involved in the increase in skeletal muscle mitochondria that occurs in response to acute exercise. Increases in mitochondrial volume that occur following exercise training are most likely a result of gene activation following each acute exercise bout, as well as chronic effects of repeated exercise bouts.
The molecular events that activate mitochondrial biogenesis after contraction/exercise by increasing PGC-1␣, NRF-1, and NRF-2 have not been fully elucidated. The sarcoplasmic reticulum releases Ca 2ϩ such that there are transient increases in cytosolic Ca 2ϩ concentration for each contraction. In addition, the energy-sensing enzyme AMP-activated protein kinase (AMPK), which appears to be important in energy substrate metabolism, is activated during exercise. Studies suggest that the increases in muscle cytosolic Ca 2ϩ levels and the activation of muscle AMPK may be responsible, at least in part, for the activation of muscle mitochondrial biogenesis after exercise (22, 23, 27) . Increasing cytosolic Ca 2ϩ levels via caffeine treatment, and the associated activation of CaMK, increase mitochondrial biogenesis markers (e.g.. PGC-1␣ and NRF-1 mRNA) and activate mitochondrial biogenesis [e.g., cytochrome-c oxidase (COX)-1 protein levels] in L6 myotubes (22) (23) (24) . Inhibitors of Ca 2ϩ release and CaMK inhibitors abolish these caffeine effects (23) . Furthermore, activation of AMPK by 5=aminoimidazole-4-carboxyamide-ribonucleoside (AICAR) increases several muscle mitochondrial metabolic enzyme levels (34) and increases PGC-1␣ protein expression in rat muscle (24) and L6 myotubes (22, 27, 31) . Injecting rats once per day with AICAR (10, 18, 34) or activating AMPK via other means (3) appears to mimic exercise training in that it increases some skeletal muscle oxidative phosphorylation enzymes, as well as increasing NRF-1 and glucose transporter (GLUT)-4.
It has also been shown that nitric oxide (NO) donors and analogs of the major downstream messenger of NO, cGMP, increase mitochondrial biogenesis (e.g., increases PGC-1␣ and NRF-1 mRNA and COX-4 protein expression) in L6 myotubes (20) . Similarly, we have shown that ingestion of the nonspecific NO synthase (NOS) inhibitor N G -nitro-L-arginine methyl ester (L-NAME) for 2 days reduces basal skeletal muscle mitochondrial biogenesis in rat skeletal muscle (33) and endo-thelial NOS (eNOS) knockout (KO) mice have lower skeletal muscle mitochondrial biogenesis markers in some (20) , but not all (32) , studies. Since NO production, NOS activity, and cGMP content increase during contraction in rodent skeletal muscle (2, 28, 29) , it is possible that NO may be involved in the upregulation of mitochondrial biogenesis after exercise. However, we found that ingestion of the L-NAME for 2 days had no effect on the increase in mitochondrial biogenesis after an acute bout of exercise (33) , and also that the increase in mitochondrial biogenesis markers in response to acute exercise and exercise training is intact in neuronal NOS (nNOS) KO and eNOS KO mice (32) . Therefore, this data suggest that there is little involvement of NOS in the activation of mitochondrial biogenesis following exercise.
Despite this, there is reason to believe that activation of mitochondrial biogenesis by caffeine and AICAR in L6 myotubes may occur, at least in part, via activation of NOS. Skeletal muscle nNOS and eNOS are Ca 2ϩ -dependent enzymes. The calcium ionophore A23187 increases NO production in C 2 C 12 myotubes, and this can be prevented by L-NAME (7) . In addition, our laboratory has shown that AMPK phosphorylates nNOS in human skeletal muscle (5) , and AMPK phosphorylates and activates eNOS in rat heart (6). Therefore, it is possible that, during exercise, the observed increase in NOS activity is caused by an increase in cytosolic Ca 2ϩ , and/or the phosphorylation of NOS by AMPK, with the increase in NO then triggering mitochondrial biogenesis after exercise. If activation of AMPK and/or increases in cytosolic Ca 2ϩ stimulate mitochondrial biogenesis via NO, then the inhibition of NOS (using pharmacological NOS inhibitors, such as L-NAME) should block this effect. No study has previously examined this.
Therefore, the aim of this study was to determine whether caffeine and AICAR increase muscle mitochondrial biogenesis in L6 myotubes via NOS. We also examined the effect of AICAR, caffeine, and the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) on AMPK and CaMK signaling to further understand the mechanisms involved. We hypothesized that NOS inhibition would attenuate the increase in skeletal muscle mitochondrial biogenesis markers caused by exposure to caffeine and AICAR by attenuating the increases in phospho-(P)-CaMK and P-AMPK, respectively.
MATERIALS AND METHODS
Cell culture. L6 rat myocytes were cultured in growth media [DMEM containing 10% horse serum, 5% fetal bovine serum, 1% bovine serum albumin, 1% penicillin and streptomycin, 1 mM Lcarnitine, and 0.5 mM oleic acid (22, 23) ] on a six-well plate coated with type I collagen at 37°C until 80% confluency. They were induced to differentiate into myotubes following media change into DMEM with 2% horse serum and 1% penicillin and streptomycin. Eight different treatments were used: no treatment (control); 100 M L-NAME (16, 30) ; 100 M SNAP (NO donor) (19) Ϯ 100 M L-NAME; 2 mM AICAR (22, 23) Ϯ 100 M L-NAME; or 5 mM caffeine (22, 23) Ϯ 100 M L-NAME. Treatments were applied for 5 h per day for 5 days in growth media. Each experiment involved quadruplicate repeats of each treatment in three separate experiments. In addition, the effect of acute exposure to caffeine (5 mM, 1 h), AICAR (2 mM, 5 h), and SNAP (100 M, 1 or 5 h), with and without NOS inhibition (100 M L-NAME), on AMPK-␣ Thr172 phosphorylation and CAMKII Thr 286 phosphorylation was examined (N ϭ 6 -8 per treatment). AICAR was from Toronto Research Chemicals (Toronto, ON, Canada), and SNAP, caffeine, and L-NAME were from Sigma.
Analysis. Myotubes were lysed 24 h following the final day of treatment of the 5-day treatments, and following either 60 min or 5 h of acute AICAR/caffeine/SNAP exposure. Myotubes were washed in ice-cold phosphate-buffered saline and lysed in freshly prepared ice-cold buffer [50 mM Tris at pH 7.5 containing 1 mM EDTA, 10% vol/vol glycerol, 1% vol/vol Triton X-100, 50 mM NaF, 5 mM Na 4P2O7, 1 mM DTT, 1 mM PMSF, and 5 l/ml protease inhibitor cocktail (P8340, Sigma, St. Louis, MO)]. Lysates were incubated on ice for 20 min and cleared by centrifugation at 16,000 g for 20 min at 4°C. Protein concentration was determined using a bicinchoninic acid protein assay (Pierce, Rockford, IL) with bovine serum albumin as the standard.
Citrate synthase activity was measured spectrophotometrically on a 96-well plate at room temperature by following the increase in 5,5=-dithiobis-2-nitrobenzoate at 412 nm using the myotube lysates and expressed in micromoles per minute per gram of total protein (32) .
Total lysates for determination of PGC-1␣, COX-1, COX-4, AMPK-␣, and CaMKII were prepared for SDS-PAGE in Laemmli sample buffer. Total protein (4 g of total protein for COX-1 and COX-4 blots, 80 g for PGC-1␣ blots, and 50 g for AMPK-␣ and CAMKII blots) were separated by SDS-PAGE and transferred to PVDF membranes. Blots were probed with anti-PGC-1␣ rabbit polyclonal (Calbiochem, Darmstadt, Germany, catalog no. 516557; which migrates at ϳ95 kDa), anti-COX- Values were compared using one-way ANOVA. The Fishers least significant difference post hoc test was then used when a significant interaction was identified. The significance level was set at P Ͻ 0.05.
RESULTS
Compared with control cells, NOS inhibition by L-NAME had no effect on PGC-1␣, COX-1, and COX-4 protein expression (Figs. 1-3) . Confirming results by others (22, 27, 31) , we found that AICAR, caffeine, and SNAP all significantly (P Ͻ 0.05) increased COX-1 and COX-4 protein expression compared with control cells by one-to twofold (Figs. 1-3 ). In addition, PGC-1␣ protein content increased with AICAR and caffeine, as demonstrated by others (22) . As expected, the increase in COX-1 and COX-4 protein expression in response to the NO donor SNAP was not significantly reduced by NOS inhibition (Fig. 1) . This is because NO donors increase NO levels downstream of NOS activation. The AICAR-induced increase and the caffeine-induced increase in COX-1 and COX-4 protein expression were prevented by L-NAME (Figs.  2 and 3 ). Acute exposure of L6 myotubes to caffeine increased P-CaMK without affecting P-AMPK (P Ͻ 0.05, Figs. 4 and 5, respectively). Acute AICAR exposure increased P-AMPK, but also increased P-CaMK (P Ͻ 0.05, Figs. 4 and 5, respectively). NOS inhibition alone had no effect on P-AMPK, but surprisingly increased P-CaMK. SNAP increased P-AMPK and P-CaMK, and NOS inhibition did not reduce these effects (Figs. 4 and 5, respectively). Citrate synthase activity increased with caffeine and SNAP exposure, and NOS inhibition had no effect on these increases (Fig. 6 ).
DISCUSSION
The major finding of this study was that the AMPK activator AICAR and caffeine (which increases intracellular Ca 2ϩ ) both increase mitochondrial biogenesis in L6 myotubes, at least in part, via NOS. This is shown schematically in Fig. 7 . The study also confirmed previous findings that NO donors increase mitochondrial biogenesis in L6 myotubes. It is possible that these findings are relevant to the factors activating mitochondrial biogenesis in skeletal muscle following exercise. However, we have previously shown that both NOS inhibition in vivo in rats, and eNOS and nNOS null mice in vivo, have normal increases in mitochondrial biogenesis in response to exercise (32, 33) . We thus suggest the NOS effects shown here have a role in the maintenance of skeletal muscle mitochondrial biogenesis in the basal state. Noncontracting L6 myotubes were utilized in the current study, consistent with this interpretation.
Consistent with the present study, Nisoli et al. (20) reported that NO donors increase mitochondrial biogenesis in L6 cells. They also found that cGMP elicited similar effects as those of NO donors. However, the present study extended on these findings by examining the signaling involved. We found that the NO donor SNAP actually increased P-AMPK and PCaMK, and, therefore, it is possible that the increases in mitochondrial biogenesis with SNAP may have been due, at least in part, to the NO activation of these pathways, since AICAR/AMPK and caffeine/CaMK also activate mitochondrial biogenesis (22) (Figs. 2 and 3) . Interestingly, the increases in COX-1 and COX-4 by AICAR and caffeine were attenuated by NOS inhibition, suggesting that NOS may lie both upstream and downstream of AMPK and CaMK. Indeed, Lira et al. (16) reported that inhibition of AMPK activity prevented SNAP induction of GLUT-4 mRNA in L6 myotubes and concluded that a feedback loop could exist where AMPK activates NOS, and NO production in turn further activates AMPK. Follow-up experiments involving inhibition of AMPK and CaMK are, therefore, necessary to determine whether the effects of SNAP on mitochondrial biogenesis are independent of AMPK and CaMK.
We found that caffeine increased PGC-1␣, COX-1, and COX-4 protein in L6 myotubes, as has been shown previously (23) . Importantly, caffeine increased P-CaMK without influencing P-AMPK in L6 myotubes. Therefore, the effects of caffeine on mitochondrial biogenesis are unlikely to be due to CaMKK activating AMPK, which has been shown in whole muscle (11) . NOS inhibition attenuated the caffeine-induced increases in COX-1 and COX-4; however, since NOS inhibition also attenuated the increase in P-CaMK, it is unclear what caused the effects on COX-1 and COX-4. Interestingly, NOS inhibition did not attenuate the increases in PGC-1␣ or citrate , and PGC-1␣ (bottom) protein expression in L6 rat myotubes following exposure for 5 h/day over 5 days to either no treatment (control), 100 M L-NAME, 2 mM 5-aminoimidazole-4-carboxamide-ribonucleoside (AICAR), or 2 mM AICAR ϩ 100 M L-NAME. Values are means Ϯ SE; N ϭ 12 per treatment. Boxes around representative blots indicate that the blots were obtained from different parts of the same gel/membrane. P Ͻ 0.05: *vs. control, †vs. L-NAME, #vs. L-NAME ϩ AICAR. Fig. 3 . COX-1 (top), COX-4 (middle), and PGC-1␣ (bottom) protein expression in L6 rat myotubes following exposure for 5 h/day over 5 days to either no treatment (control), 100 M L-NAME, 5 mM caffeine, or 5 mM caffeine ϩ 100 M L-NAME. Values are means Ϯ SE; N ϭ 12 per treatment. Boxes around representative blots indicate that the blots were obtained from different parts of the same gel/membrane. P Ͻ 0.05: *vs. control, †vs. L-NAME, #vs. L-NAME ϩ caffeine. synthase activity by caffeine. This suggests that mechanisms in addition to CaMK and NO are responsible for the activation of some aspects of mitochondrial biogenesis by caffeine.
As has been the case in previous studies, we found that AICAR increased PGC-1␣, COX-1, and COX-4 protein in L6 myotubes (22, 23) . Similar to what we found with caffeine, NOS inhibition attenuated the increases in COX-1 and COX-4 protein. However, again, there was evidence of cross-signaling in that not only did AICAR increase P-AMPK, but it also increased P-CaMK. However, since the NOS inhibitor L-NAME actually augmented AICAR-induced increases in PCaMK, but at the same time COX-1 and COX-4 protein were diminished, this suggests that the effects of AICAR were indeed via AMPK and NO.
Interestingly, the increases in COX-1 and COX-4 protein in response to caffeine and AICAR were attenuated by NOS Fig. 4 . CaMKII Thr 286 phosphorylation in L6 rat myotubes following acute 1 or 5 h exposure to no treatment (control), 100 M L-NAME, 2 mM AICAR, or 2 mM AICAR ϩ 100 M L-NAME (L; A); no treatment (control), 100 M L-NAME, 5 mM caffeine, or 5 mM caffeine ϩ 100 M L-NAME (B); or no treatment (control), 100 M L-NAME, 100 M SNAP, or 100 M SNAP ϩ 100 M L-NAME (C). Values are means Ϯ SE; N ϭ 6 -8 per treatment. Boxes around representative blots indicate that the blots were obtained from different parts of the same gel/membrane. P Ͻ 0.05 vs. *control, †L-NAME, #AICAR or caffeine. Fig. 5 . AMP-activated protein kinase (AMPK)-␣ Thr 172 phosphorylation (p-AMPK-␣) in L6 rat myotubes following acute 1 or 5 h exposure to no treatment (control), 100 M L-NAME, 2 mM AICAR, or 2 mM AICAR ϩ 100 M L-NAME (L; A); no treatment (control), 100 M L-NAME, 5 mM caffeine, or 5 mM caffeine ϩ 100 M L-NAME (B); or no treatment (control), 100 M L-NAME, 100 M SNAP, or 100 M SNAP ϩ 100 M L-NAME (C). Values are means Ϯ SE; N ϭ 6 -8 per treatment. Boxes around representative blots indicate that the blots were obtained from different parts of the same gel/membrane. P Ͻ 0.05 vs. *control, †L-NAME, #SNAP.
inhibition, but this occurred without any effect on PGC-1␣ protein content. At first, this is a surprising result, since PGC-1␣ is widely considered the master regulator of mitochondrial biogenesis. However, recent evidence suggests that the effects of PGC-1␣ are based on not only its level of protein expression, but also the extent of PGC-1␣ phosphorylation, deacetylation, and translocation into the nucleus (8, 35) . In addition, PGC-1␣ KO mice have essentially normal increases in skeletal muscle mitochondrial biogenesis with exercise (14) , suggesting that mitochondrial biogenesis can be induced independently of PGC-1␣.
The reason that L-NAME attenuates the activation of mitochondrial biogenesis by AICAR and caffeine in L6 myotubes (Figs. 2 and 3 ), but does not attenuate the activation of mitochondrial biogenesis during exercise (33) , when increases in AMPK activity and intramuscular calcium occur, may relate to redundancy of signaling during exercise. Indeed, recent studies show that not only is skeletal muscle mitochondrial biogenesis normal in response to exercise following L-NAME treatment (33) , and in eNOS and nNOS KO mice (32) , but also it is normal in AMPK ␣ 2 -KO mice, which have greatly reduced activation of AMPK during contraction (12) . It is likely, therefore, that, since exercise activates multiple signaling pathways that activate mitochondrial biogenesis (e.g., calcium/ CaMK, AMPK, p38 MAPK, NO/cGMP, reactive oxygen species. etc.), blocking one pathway is not sufficient, or results in compensations in the other pathways, such that the activation of skeletal muscle mitochondrial biogenesis by exercise is preserved.
Lira et al. (16) reported that SNAP increased GLUT-4 protein expression in L6 myotubes and that inhibition of guanylate cyclase could prevent this increase. They also found Fig. 6 . Citrate synthase activity in L6 rat myotubes following exposure over 5 days to either no treatment (control), 100 M L-NAME, 2 mM AICAR, or 2 mM AICAR ϩ 100 M L-NAME (L; A); no treatment (control), 100 M L-NAME, 5 mM caffeine, or 5 mM caffeine ϩ 100 M L-NAME (B); or no treatment (control), 100 M L-NAME, 100 M SNAP, or 100 M SNAP ϩ 100 M L-NAME (C). Values are means Ϯ SE; N ϭ 12 per treatment. P Ͻ 0.05 vs. *control, †L-NAME. Fig. 7 . Proposed pathways for the regulation of mitochondrial biogenesis by caffeine, AICAR, and the interaction with nitric oxide synthase (NOS)/nitric oxide (NO). Skeletal muscle neuronal NOS and endothelial NOS are Ca 2ϩ -dependent enzymes, and skeletal muscle calcium levels increase in response to caffeine (and muscle contraction). In addition, AICAR activates skeletal muscle AMPK, and it has been shown that AMPK phosphorylates neuronal NOS and endothelial NOS. Therefore, we suggest that AICAR and caffeine increase mitochondrial biogenesis, in part, via interactions with NOS. Indeed, we found that NOS inhibition attenuated the activation of some aspects of mitochondrial biogenesis in response to AICAR and caffeine.
that the increase in GLUT-4 protein in response to AICAR could be prevented by L-NAME in L6 myotubes (16) . Therefore, it appears likely that NO activates mitochondrial biogenesis and increases GLUT-4 in parallel. These data are consistent with increases in mitochondrial biogenesis markers and GLUT-4 by AICAR occurring via NOS activation (see Fig. 5 ).
In conclusion, AICAR and caffeine increase mitochondrial biogenesis in L6 myotubes, in part, via interaction with NOS. In addition, NO donors increase mitochondrial biogenesis in L6 myotubes. 
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